Gabelli Funds’s GeneDx Holdings WGS Stock Holding History

Gabelli Funds’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-682	Closed	-$20K	–	1252
2022 Q3	$20K	Hold	682	–	–	﹤0.01%	1235
2022 Q2	$28K	Hold	682	–	–	﹤0.01%	1268
2022 Q1	$69K	Buy	682 +303	+80%	+$33.7K	﹤0.01%	1296
2021 Q4	$56K	Buy	+379	New	+$84.7K	﹤0.01%	1325

Other funds holding WGS

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Gabelli Funds's WGS Position: Q4 2022 in Review

Gabelli Funds sold out of GeneDx Holdings (WGS) in Q4 2022, closing a stake of 682 shares — an estimated $20K sold.

Gabelli Funds first reported a position in WGS in Q4 2021 and held it in 4 quarters. The position peaked at $69K in Q1 2022. 86 funds tracked by Wall St. Rank hold WGS as of Q4 2022.

Gabelli Funds reported no remaining GeneDx Holdings position as of Q4 2022 after selling out during the quarter.
Gabelli Funds sold 682 GeneDx Holdings shares in Q4 2022, an estimated $20K.
Gabelli Funds first reported a position in GeneDx Holdings in Q4 2021 and held it in 4 quarters.
Gabelli Funds's GeneDx Holdings position peaked at $69K in Q1 2022.
86 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2022.

Based on Gabelli Funds's 13F filing for Q4 2022, filed 13 Feb 2023.